{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:08:51Z","timestamp":1791403731669,"version":"4.3.3"},"reference-count":384,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.pharmthera.2005.12.004","type":"journal-article","created":{"date-parts":[[2006,2,25]],"date-time":"2006-02-25T07:16:10Z","timestamp":1140851770000},"page":"674-706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":266,"title":["5-Hydroxytryptamine receptors in the human cardiovascular system"],"prefix":"10.1016","volume":"111","author":[{"given":"Alberto J.","family":"Kaumann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn Olav","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2005.12.004_bib1","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/0024-3205(81)90566-X","article-title":"Reduced uptake of serotonin but unchanged 3H-imipramine binding in the platelets from cirrhotic patients","volume":"29","author":"Ahtee","year":"1981","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1152\/ajplegacy.1972.222.2.345","article-title":"Effects of vasoactive agents on isolated human umbilical arteries and veins","volume":"222","author":"Altura","year":"1972","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib3","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/0024-3205(87)90696-5","article-title":"Steady-state model for plasma free and platelet serotonin in man","volume":"41","author":"Anderson","year":"1987","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1124\/mol.105.015396","article-title":"Activation of adenylyl cyclase by endogenous Gs-coupled receptors in HEK293 cells is attenuated by 5-HT7 receptor expression","volume":"69","author":"Andressen","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib5","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1055\/s-0037-1614586","article-title":"A synergistic effect of serotonin transporter gene polymorphism and smoking in association with coronary heart disease","volume":"81","author":"Arinami","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0304-3940(96)13094-9","article-title":"Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine","volume":"217","author":"Arranz","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0920-9964(98)00032-2","article-title":"Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response","volume":"32","author":"Arranz","year":"1998","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s002100000299","article-title":"5-HT4(a) and 5-HT4(b) receptors have nearly identical pharmacology and are both expressed in human atrium and ventricle","volume":"363","author":"Bach","year":"2001","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib9","doi-asserted-by":"crossref","first-page":"23422","DOI":"10.1016\/S0021-9258(19)49479-9","article-title":"Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase","volume":"268","author":"Bard","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF00614304","article-title":"The action of cisapride on gastric emptying and the pharmacodynamics and pharmacokinetics of oral diazepam","volume":"30","author":"Bateman","year":"1986","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib11","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/BF00168940","article-title":"5-Hydroxytryptamine-induced contractions of human isolated saphenous vein: involvement of 5-HT2 and 5-HT1D-like receptors, and a comparison with grafted veins","volume":"345","author":"Bax","year":"1992","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib12","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/sj.bjp.0705929","article-title":"The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo","volume":"143","author":"Beattie","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib13","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/hep.1840200405","article-title":"Blood and plasma 5-hydroxytryptamine levels in patients with cirrhosis","volume":"20","author":"Beaudry","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib14","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.hrthm.2004.09.009","article-title":"How structurally normal are human atria in patients with atrial fibrillation?","volume":"1","author":"Becker","year":"2004","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib15","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0026-895X(25)10574-9","article-title":"Cloning and functional expression of a human 5-hydroxytryptamine type 3AS receptor subunit","volume":"48","author":"Belelli","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib16","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1177\/000331979004101112","article-title":"Platelet aggregation is not necessary for occurrence of Raynaud's phenomenon: a clinical history and laboratory results","volume":"41","author":"Bellucci","year":"1990","journal-title":"Angiology"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib18","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1046\/j.1471-4159.2000.740478.x","article-title":"Structure of the human serotonin 5-HT4 receptor gene and cloning of a novel 5-HT4 splice variant","volume":"74","author":"Bender","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib17","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1016\/j.febslet.2005.04.040","article-title":"Constitutive dimerization of human serotonin 5-HT4 receptors in living cells","volume":"579","author":"Berthouze","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib19","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00228-002-0552-4","article-title":"Raynaud's phenomenon induced by drugs acting on neurotransmission: two cases under reboxetine and one under tegaserod","volume":"58","author":"Bertoli","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib20","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/jcp.42.7.716","article-title":"Abnormal platelet aggregation in patients with Raynaud's phenomenon","volume":"42","author":"Biondi","year":"1989","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0167-5273(88)90238-0","article-title":"Plasma free and intraplatelet serotonin in patients with Raynaud's phenomenon","volume":"19","author":"Biondi","year":"1988","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1113\/jphysiol.1959.sp006174","article-title":"The effect of precursors of 5-hydroxytryptamine on gastric secretion in anaesthetized dogs","volume":"146","author":"Black","year":"1959","journal-title":"J Physiol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib23","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.cardiores.2003.09.015","article-title":"Serotonin 5-HT2B receptor loss of function mutation in a patient with fenfluramine-associated primary pulmonary hypertension","volume":"60","author":"Blanpain","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib24","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/00004872-198812040-00006","article-title":"5-HT3 receptor-mediated vasodilation in the human forearm","volume":"6","author":"Blauw","year":"1988","journal-title":"J Hypert Suppl"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib25","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/S0140-6736(00)05118-7","article-title":"Raynaud's phenomenon","volume":"357","author":"Block","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib26","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0014-5793(97)00820-X","article-title":"Molecular and functional characterization of a 5-HT4 receptor cloned from human atrium","volume":"412","author":"Blondel","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib27","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1046\/j.1471-4159.1998.70062252.x","article-title":"Cloning, expression, and pharmacology of four human 5-hydroxytryptamine4 receptor isoforms produced by alternative splicing in the carboxyl terminus","volume":"70","author":"Blondel","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0014-2999(92)90488-P","article-title":"Heterogeneity of contractile 5-hydroxytryptamine receptors in human hand veins","volume":"219","author":"Bodelsson","year":"1992","journal-title":"Eur. J. Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib29","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1046\/j.1471-4159.1995.64031401.x","article-title":"Ultrastructure of the 5-hydroxytryptamine3 receptor","volume":"64","author":"Boess","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib30","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1476-5381.1995.tb14977.x","article-title":"The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors","volume":"115","author":"Bonhaus","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib31","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1046\/j.1468-2982.2001.218233.x","article-title":"Vascular effects of the new anti-migraine agent almotriptan on human cranial and peripheral arteries","volume":"21","author":"Bou","year":"2001","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib32","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/01.RES.80.3.354","article-title":"Arrhythmogenicity of IgG and anti-52 kD SSA\/Ro affinity-purified antibodies from mothers of children with congenital heart block","volume":"80","author":"Boutjdir","year":"1997","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib33","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/sj.bjp.0703081","article-title":"No contractile effect of 5-HT1D and 5-HT1F receptor agonists in human and bovine cerebral arteries: similarity with human coronary artery","volume":"129","author":"Bouchelet","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/10606820212394","article-title":"Agonist-like activity of antibodies directed against the second extracellular loop of the human cardiac serotonin 5-HT4(e) receptor in transfected COS-7 cells","volume":"8","author":"Bozon","year":"2002","journal-title":"Receptors Channels"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib35","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s00210-004-0919-4","article-title":"Cloning, pharmacological characterisation and tissue distribution of a novel 5-HT4 receptor splice variant, 5-HT4(i)","volume":"369","author":"Brattelid","year":"2004","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00210-004-0963-0","article-title":"Functional serotonin 5-HT4 receptors in porcine and human ventricular myocardium with increased 5-HT4 mRNA in heart failure","volume":"370","author":"Brattelid","year":"2004","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib37","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000116762","article-title":"The safety and tolerability of sumatriptan: an overview","volume":"31","author":"Brown","year":"1991","journal-title":"Eur Neurol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/10606820308245","article-title":"Unaltered agonist potency upon inducible 5-HT7(a) but not 5-HT4(b) receptor expression indicates agonist-independent association of 5-HT7(a) receptor and Gs","volume":"9","author":"Bruheim","year":"2003","journal-title":"Receptors Channels"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib39","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1749-6632.1998.tb10196.x","article-title":"Molecular cloning of alternatively spliced human 5-HT3 receptor cDNAs","volume":"861","author":"Br\u00fcss","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib40","first-page":"95","article-title":"Modified ligand binding to the naturally occurring Cys-124 variant of the human serotonin 5-HT1B receptor","volume":"9","author":"Br\u00fcss","year":"1999","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib41","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuint.2005.03.003","article-title":"Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor","volume":"47","author":"Br\u00fcss","year":"2005","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib42","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF00547426","article-title":"Pharmacokinetics of fenfluramine and norfenfluramine in volunteers given d- and dl-fenfluramine for 15 days","volume":"29","author":"Caccia","year":"1985","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib43","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/10290","article-title":"Characterization of single-nucleotide polymorphisms in coding regions of human genes","volume":"22","author":"Cargill","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib44","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.yjmcc.2005.04.009","article-title":"Differential functional effects of two 5-HT4 receptor isoforms in adult cardiomyocytes","volume":"39","author":"Castro","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib45","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0026-895X(24)26469-5","article-title":"Preactivation permits subsequent stimulation of phospholipase C by Gi-coupled receptors","volume":"57","author":"Chan","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib46","first-page":"153","article-title":"Serotonergic mechanisms in heart failure","volume":"46","author":"Chandra","year":"1994","journal-title":"Indian Heart J"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib47","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/cvr\/24.11.932","article-title":"5-Hydroxytryptamine receptor profile in healthy and diseased human epicardial coronary arteries","volume":"24","author":"Chester","year":"1990","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib48","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.CIR.87.3.874","article-title":"Interactions between thromboxane A2 and 5-hydroxytryptamine receptor subtypes in human coronary arteries","volume":"87","author":"Chester","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib49","first-page":"238","article-title":"The association between the T102C polymorphism of the HTR2A serotonin receptor gene and HDL cholesterol level in Koreans","volume":"38","author":"Choi","year":"2005","journal-title":"J Biochem Mol Biol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib50","unstructured":"Christ, T., Ravens, U., & Kaumann, A. J. (2005). 5-Hydroxytryptamine-induced increases of contractility, but not of L-type calcium current, are markedly reduced in atrial myocardium from atrial fibrillation patients with or without heart failure. Proceedings of the 3rd James Black Conference, Pharmacological Insights and Therapeutic Targets in Heart Failure, Christ Church College, Oxford, 18\u201320 September, P002."},{"key":"10.1016\/j.pharmthera.2005.12.004_bib51","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/ajmg.1473","article-title":"Novel and previously reported single-nucleotide polymorphisms in the human 5-HT1B receptor gene: no association with cocaine or alcohol abuse or dependence","volume":"105","author":"Cigler","year":"2001","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib52","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1097\/00001756-199710200-00002","article-title":"Cloning and expression of human 5-HT4S receptors. Effect of receptor density on their coupling to adenylyl cyclase","volume":"8","author":"Claeysen","year":"1997","journal-title":"NeuroReport"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib53","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1749-6632.1998.tb10172.x","article-title":"5-HT4 receptors: cloning and expression of new splice variants","volume":"861","author":"Claeysen","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib54","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0026-895X(24)23188-6","article-title":"Novel brain-specific 5-HT4 receptor splice variants show marked constitutive activity: role of the C-terminal intracellular domain","volume":"55","author":"Claeysen","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib55","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1476-5381.1992.tb12788.x","article-title":"5-Hydroxytryptamine (5-HT) mediates potent relaxation in the sheep isolated pulmonary vein via activation of 5-HT4 receptors","volume":"107","author":"Cocks","year":"1992","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib56","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1476-5381.1993.tb13818.x","article-title":"Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist U46619","volume":"110","author":"Cocks","year":"1993","journal-title":"Br J Pharmacol"},{"issue":"Heart Circ Physiol 23","key":"10.1016\/j.pharmthera.2005.12.004_bib57","first-page":"H889","article-title":"Serotonergic vasoconstriction in human fingers during reflex sympathetic responses to cooling","volume":"254","author":"Coffman","year":"1988","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib58","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1042\/cs0860269","article-title":"Plasma levels of 5-hydroxytryptamine during sympathetic stimulation and in Raynaud's phenomenon","volume":"86","author":"Coffman","year":"1994","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib59","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/00004647-199908000-00010","article-title":"Multiple microvascular and astroglial 5-hydroxytryptamine receptor subtypes in human brain: molecular and pharmacological characterization","volume":"19","author":"Cohen","year":"1999","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib60","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/rheumatology\/40.9.1038","article-title":"Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine","volume":"40","author":"Coleiro","year":"2001","journal-title":"Rheumatology"},{"issue":"Suppl 2","key":"10.1016\/j.pharmthera.2005.12.004_bib61","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1046\/j.1526-4610.42.s2.2.x","article-title":"Pharmacology of the selective 5-HT1B\/D agonist frovatriptan","volume":"42","author":"Comer","year":"2002","journal-title":"Headache"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib62","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1523\/JNEUROSCI.2806-03.2004","article-title":"Attenuated response to stress and novelty and hypersensitivity to seizures in 5-HT4 receptor knock-out mice","volume":"24","author":"Compan","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib63","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199708283370901","article-title":"Valvular heart disease associated with fenfluramine-phentermine","volume":"337","author":"Connolly","year":"1997","journal-title":"New Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib64","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0014-2999(89)90184-2","article-title":"5-Hydroxytryptamine contracts human coronary arteries predominantly via 5-HT2 receptor activation","volume":"161","author":"Connor","year":"1989","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib65","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0026-895X(25)08735-8","article-title":"Activation of 5-hydroxytryptamine4 receptors causes calcium influx in adrenocortical cells: involvement of calcium in 5-hydroxytryptamine-induced steroid secretion","volume":"49","author":"Contesse","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib66","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0014-2999(90)90529-F","article-title":"Role of 5-HT2 receptors in serotonin-induced contraction in the human mammary artery","volume":"176","author":"Conti","year":"1990","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib67","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/sj.bjp.0701509","article-title":"Characterization of 5-HT receptors on human pulmonary artery and vein: functional and binding studies","volume":"122","author":"Cortijo","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib68","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1210\/jcem.86.9.7837","article-title":"Expression and regulation of adenylyl cyclase isoforms in the human adrenal gland","volume":"86","author":"C\u00f4t\u00e9","year":"2001","journal-title":"J Clin Endocr Metab"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib69","doi-asserted-by":"crossref","first-page":"13525","DOI":"10.1073\/pnas.2233056100","article-title":"Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function","volume":"100","author":"C\u00f4t\u00e9","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib70","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1042\/cs1040241","article-title":"5-Hydroxytryptamine 5-HT2A receptor and 5-hydroxytryptamine transporter polymorphisms in acute myocardial infarction","volume":"104","author":"Coto","year":"2003","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib71","first-page":"1736","article-title":"Ergotamine-induced heart valve fibrosis and coronary microangiopathy?","volume":"117","author":"Creutzig","year":"1992","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib72","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1476-5381.1986.tb11150.x","article-title":"Hypersensitivity of mesenteric veins to 5-hydroxytryptamine- and ketanserin-induced reduction of portal pressure in portal hypertensive rats","volume":"89","author":"Cummings","year":"1986","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib73","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/hep.1840080523","article-title":"Comparison of the hemodynamic responses to ketanserin and prazosin in portal hypertensive rats","volume":"8","author":"Cummings","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib74","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/bmj.305.6855.713-d","article-title":"Cardiorespiratory distress after sumatriptan given by injection","volume":"305","author":"Curtin","year":"1992","journal-title":"Br Med J"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib75","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/16941","article-title":"The 5-HT3B subunit is a major determinant of serotonin-receptor function","volume":"397","author":"Davies","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib76","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1161\/01.CIR.69.5.889","article-title":"A double-blind, placebo-controlled study of ketanserin in patients with Prinzmetal's angina. Evidence against a role for serotonin in the genesis of coronary vasospasm","volume":"69","author":"DeCaterina","year":"1984","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib77","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1016\/0006-2952(84)90699-3","article-title":"Evidence for functional 5-HT2 receptor sites on human blood platelets","volume":"33","author":"De Clerck","year":"1984","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib78","doi-asserted-by":"crossref","first-page":"7603","DOI":"10.1016\/S0021-9258(17)39651-5","article-title":"Evidence that phospholipid turnover is the signal transducing system coupled to serotonin-S2 receptor sites","volume":"260","author":"De Chaffoy de Courcelles","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib79","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.bcp.2003.09.030","article-title":"Pharmacology of polymorphic variants of the human 5-HT1A receptor","volume":"67","author":"Del Tredici","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib80","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1124\/mol.104.008268","article-title":"The natural mutation encoding a C terminus-truncated 5-hydroxytryptamine2B receptor is a gain of proliferative functions","volume":"67","author":"Deraet","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib81","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/10606820490514950","article-title":"Polyclonal antibody effects on the human cardiac 5-HT4(e) receptors depend upon the expression system","volume":"10","author":"Di Scala","year":"2004","journal-title":"Receptors Channels"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib82","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1476-5381.1986.tb11122.x","article-title":"An examination of 5-hydroxytryptamine receptors in human saphenous vein","volume":"89","author":"Docherty","year":"1986","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib83","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1526-4610.2004.04078.x","article-title":"The Triptan Cardiovascular Safety Expert Panel. Consensus statement: cardiovascular safety profile of triptans (5-HT1B\/1D agonists) in the acute treatment of migraine","volume":"44","author":"Dodick","year":"2004","journal-title":"Headache"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib84","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/sj.mp.4001403","article-title":"Polymorphisms in the 5\u2032-untranslated region of the human serotonin receptor 1B (HTR1B) gene affect gene expression","volume":"8","author":"Duan","year":"2003","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib85","doi-asserted-by":"crossref","first-page":"30799","DOI":"10.1074\/jbc.274.43.30799","article-title":"The pharmacological and functional characteristics of the serotonin 5-HT3A receptor are specifically modified by a 5-HT3B receptor subunit","volume":"274","author":"Dubin","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib86","first-page":"17A","article-title":"Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension","volume":"21","author":"Duprez","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib87","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1172\/JCI107893","article-title":"Mechanism mediating bradycardia during coronary arteriography","volume":"54","author":"Eckberg","year":"1974","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib88","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1172\/JCI200112805","article-title":"Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension","volume":"108","author":"Eddahibi","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib89","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1161\/01.CIR.0000091409.53101.E8","article-title":"Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease","volume":"108","author":"Eddahibi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib90","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/1521-4141(200010)30:10<2782::AID-IMMU2782>3.0.CO;2-9","article-title":"Anti-SSA\/Ro52 autoantibodies blocking the cardiac 5-HT4 serotoninergic receptor could explain neonatal lupus congenital heart block","volume":"30","author":"Eftekhari","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib91","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/1521-4141(200102)31:2<573::AID-IMMU573>3.0.CO;2-9","article-title":"Induction of neonatal lupus of mice immunized with synthetic peptides derived from amino acid sequences of the serotoninergic 5-HT4 receptor","volume":"31","author":"Eftekhari","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib92","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.cardiores.2003.10.017","article-title":"The tantalizing triplet of pulmonary hypertension-BMP receptors, serotonin receptors, and angiopoietins","volume":"60","author":"Eickelberg","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib93","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/sj.bjp.0703763","article-title":"Sumatriptan elicits both constriction and dilation in human and bovine brain intracortical arterioles","volume":"132","author":"Elhusseiny","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib94","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1073\/pnas.96.12.7059","article-title":"Progressive hypertrophy and heart failure in \u03b21-adrenergic receptor transgenic mice","volume":"96","author":"Engelhardt","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib95","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/BF02281871","article-title":"Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia","volume":"97","author":"Erdmann","year":"1996","journal-title":"Hum Genet"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib96","first-page":"392","article-title":"The human serotonin 7 (5-HT7) receptor gene: genomic organization and systematic mutation screening in schizophrenia and bipolar affective disorder","volume":"1","author":"Erdmann","year":"1996","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib98","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra035488","article-title":"Pulmonary arterial hypertension","volume":"351","author":"Farber","year":"2004","journal-title":"New Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib99","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1172\/JCI113569","article-title":"Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in failing human heart","volume":"82","author":"Feldman","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib100","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/hep.1840180224","article-title":"Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splachnic hemodynamics in rats with long-term bile duct ligation","volume":"18","author":"Fernandez","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib101","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0046-8177(76)80054-8","article-title":"The carcinoid endocardial plaque: an ultrastructural study","volume":"7","author":"Ferrans","year":"1976","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib102","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/01.CIR.99.1.156","article-title":"Aminorex to fen\/phen: an epidemic foretold","volume":"99","author":"Fishman","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib103","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0026-895X(24)26444-0","article-title":"Possible role of valvular serotonin 5-HT2B receptors in the cardiopathy associated with fenfluramine","volume":"57","author":"Fitzgerald","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib104","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/nar\/gkh536","article-title":"Evidence that RNA editing modulates splice site selection in the 5-HT2C receptor gene","volume":"32","author":"Flomen","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib105","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1159\/000138854","article-title":"Pharmacological characterization of the postsynaptic serotonergic receptor in the human uterine artery","volume":"43","author":"Fontes Ribeiro","year":"1991","journal-title":"Pharmacology"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib106","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/00005344-198209000-00020","article-title":"Mechanism of action of ketanserin in hypertension","volume":"4","author":"Fozard","year":"1982","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib107","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/BF00518776","article-title":"MDL72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors","volume":"326","author":"Fozard","year":"1984","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib108","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/01.CIR.70.2.178","article-title":"Ergonovine-induced myocardial ischemia: no role for serotonergic receptors?","volume":"70","author":"Freedman","year":"1984","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib109","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0140-6736(91)90005-A","article-title":"Migraine pain associated with middle cerebral artery dilation: reversal by sumatriptan","volume":"338","author":"Friberg","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib110","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJM199306243282508","article-title":"The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies","volume":"328","author":"Friedman","year":"1993","journal-title":"New Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib111","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1113\/jphysiol.2002.023374","article-title":"Activated platelets contribute to stimulation of cardiac afferents during ischaemia in cats: role of 5-HT3 receptors","volume":"544","author":"Fu","year":"2002","journal-title":"J Physiol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib112","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1161\/01.CIR.0000022603.92986.99","article-title":"Serotonin transporter gene polymorphism and myocardial infarction","volume":"105","author":"Fumeron","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib113","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/j.1460-2075.1995.tb07280.x","article-title":"The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants","volume":"14","author":"Gerald","year":"1995","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib114","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1097\/01.mcg.0000156403.37240.30","article-title":"Nerves, reflexes, and the enteric nervous system: pathogenesis of the irritable bowel syndrome","volume":"39","author":"Gershon","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib115","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ajmg.b.20056","article-title":"Re-screening serotonin receptors for genetic variants identifies population and molecular genetic complexity","volume":"124","author":"Glatt","year":"2004","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib116","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/sj.bjp.0703341","article-title":"Further evidence that 5-HT-induced relaxation of pig pulmonary artery is mediated by endothelial 5-HT2B receptors","volume":"130","author":"Glusa","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib117","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJMra010917","article-title":"Migraine\u2013current understanding and treatment","volume":"346","author":"Goadsby","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib118","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0022-3565(25)10311-X","article-title":"A comparison of the potency of selective L-calcium channel blockers in human coronary and internal mammary arteries exposed to serotonin","volume":"263","author":"Godfraind","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib119","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0140-6736(01)06347-4","article-title":"Selective serotonin 1F (5-HT1F) receptor agonist LY334370 for acute migraine: a randomised controlled trial","volume":"358","author":"Goldstein","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib120","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1056\/NEJM199103073241001","article-title":"Divergent effects of serotonin on coronary artery dimensions and blood flow in patients with coronary atherosclerosis and control patients","volume":"324","author":"Golino","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib121","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJM199402243300802","article-title":"Local effect of serotonin released during coronary angioplasty","volume":"330","author":"Golino","year":"1994","journal-title":"New Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib122","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1749-6632.1998.tb10169.x","article-title":"Genetic variation in human 5-HT receptors: potential pathogenetic and pharmacological role","volume":"861","author":"G\u00f6thert","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib123","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0014-2999(01)00933-5","article-title":"Human 5-HT5 receptors: the 5-HT5A receptor is functional but the 5-HT5B receptor was lost during mammalian evolution","volume":"418","author":"Grailhe","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib124","doi-asserted-by":"crossref","first-page":"10853","DOI":"10.1021\/bi035061z","article-title":"Identification of two serine residues essential for agonist-induced 5-HT2A receptor desensitization","volume":"42","author":"Gray","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib125","first-page":"365","article-title":"The responses of the Venus heart to catecholamines and high concentrations of 5-hydroxytryptamine","volume":"15","author":"Greenberg","year":"1960","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib126","first-page":"375","article-title":"Structure\u2013activity relationship of tryptamine analogues on the heart of Venus mercenaria","volume":"15","author":"Greenberg","year":"1960","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib127","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1006\/jmcc.1998.0769","article-title":"Inactivation of Gi\u03b1 proteins increases arrhythmogenic effects of \u03b2-adrenergic stimulation in the heart","volume":"30","author":"Grimm","year":"1998","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib128","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/hep.1840200538","article-title":"Hyperdynamic circulation in liver disease 40 years later: pathophysiology and clinical consequences","volume":"20","author":"Groszmann","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib129","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1097\/01.mcg.0000155552.14396.3d","article-title":"Portal hypertension. From bedside to bench","volume":"39","author":"Groszmann","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib130","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0006-8993(00)02664-0","article-title":"Identification and characterization of a truncated variant of the 5-hydroxytryptamine2A receptor produced by alternative splicing","volume":"876","author":"Guest","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib131","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00005344-200302000-00021","article-title":"Pharmacological characterization of contractile serotonin receptors in human isolated mesenteric artery","volume":"41","author":"Gul","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib132","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1161\/01.CIR.0000159356.42064.48","article-title":"Long-term serotonin administration induces heart valve disease in rats","volume":"111","author":"Gustafsson","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib133","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/hep.1840070405","article-title":"Beneficial hemodynamic effects of ketanserin in patients with cirrhosis: possible role of serotonergic mechanisms in portal hypertension","volume":"7","author":"Hadengue","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib134","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/hep.1840090113","article-title":"Combination of ketanserin and verapamil or propranolol in patients with alcoholic cirrhosis: search for an additive effect","volume":"9","author":"Hadengue","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib135","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJM199809033391003","article-title":"Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins","volume":"339","author":"Haissaguerre","year":"1998","journal-title":"New Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib136","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/j.jacc.2004.03.036","article-title":"Pulmonary veins in the substrate for atrial fibrillation: the \u201cvenous wave\" hypothesis","volume":"43","author":"Haissaguerre","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib137","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1161\/01.CIR.0000130645.95357.97","article-title":"Changes in atrial fibrillation cycle length and inducibility during catheter ablation and their relation to outcome","volume":"109","author":"Haissaguerre","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib138","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1161\/01.RES.66.6.1610","article-title":"Selective \u03b21-adrenoceptor blockade enhances positive inotropic responses to endogenous catecholamines mediated through \u03b22-adrenoceptors in human atrial myocardium","volume":"66","author":"Hall","year":"1990","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib139","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1212\/01.WNL.0000110312.36809.7F","article-title":"Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice","volume":"24","author":"Hall","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib140","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1073\/pnas.72.8.2994","article-title":"Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides","volume":"72","author":"Hamberg","year":"1975","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib141","first-page":"703","article-title":"Contractile 5-HT1 receptors in human isolated pial arterioles: correlation with 5-HT1D type serotonin receptors","volume":"106","author":"Hamel","year":"1991","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib142","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0026-895X(25)13136-2","article-title":"Expression of mRNA for the serotonin 5-hydroxytryptamine1D\u03b2 receptor subtype in human and bovine cerebral arteries","volume":"44","author":"Hamel","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib143","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0893-133X(97)00097-3","article-title":"Serotonin transporter and seasonal variation in blood serotonin in families with obsessive-compulsive disorder","volume":"18","author":"Hanna","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib144","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1017\/S0317167100000147","article-title":"Patophysiology of migraine\u2014new insights","volume":"26","author":"Hargreaves","year":"1999","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib145","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1161\/01.CIR.21.6.1134","article-title":"Some circulatory effects of 5-hydroxytryptamine in man","volume":"21","author":"Harris","year":"1960","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib146","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0165-6147(92)90053-9","article-title":"A subfamily of 5-HT1D receptor genes","volume":"13","author":"Hartig","year":"1992","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib147","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0165-6147(96)30002-3","article-title":"Alignment of receptor nomenclature with the human genome: classification of 5-HT1B and 5-HT1D receptor subtypes","volume":"17","author":"Hartig","year":"1996","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib149","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0378-3782(96)01778-1","article-title":"Characterization of the vasodilatatory response to serotonin in human umbilical arteries perfused in vitro. The influence of the endothelium","volume":"47","author":"Haugen","year":"1997","journal-title":"Early Human Development"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib150","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1124\/mol.66.5.1293","article-title":"His452Tyr polymorphism in the human 5-HT2A receptor destabilizes the signaling conformation","volume":"66","author":"Hazelwood","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib151","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1046\/j.1471-4159.1997.68041372.x","article-title":"Four 5-hydroxytryptamine7 (5-HT7) receptor isoforms in human and rat produced by alternative splicing: species differences due to altered intron\u2013exon organization","volume":"68","author":"Heidmann","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib152","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1046\/j.1471-4159.1996.66062621.x","article-title":"Allelic variation of human serotonin transporter gene distribution","volume":"6","author":"Heils","year":"1996","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib153","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1046\/j.1468-2982.1996.1604224.x","article-title":"Sumatriptan: vasoactive effects on human dural vessels, demonstrated by subselective angiography","volume":"16","author":"Henkew","year":"1996","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib154","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1067\/mcp.2000.110456","article-title":"Paroxetine decreases platelet serotonin storage and platelet function in human beings","volume":"68","author":"Hergovich","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib155","first-page":"564","article-title":"Sumatriptan and chest pain","volume":"341","author":"Hillis","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib156","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1161\/01.CIR.16.2.246","article-title":"Serotonin and antiserotonins: I. Their circulatory, respiratory and renal effects in man","volume":"16","author":"Hollander","year":"1957","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib157","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/mds.20201","article-title":"Severe multivalvular disease: a new complication of the ergot derived dopamine agonists","volume":"19","author":"Horvath","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib158","first-page":"676P","article-title":"The pharmacology of human isolated pulmonary vascular tissues","volume":"47","author":"Houghton","year":"1973","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib159","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0031-6997(25)06783-3","article-title":"International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin)","volume":"46","author":"Hoyer","year":"1994","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib160","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","article-title":"Molecular, pharmacological and functional diversity of 5-HT receptors","volume":"71","author":"Hoyer","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib161","first-page":"1422","article-title":"Effect of ritanserin, a serotonin antagonist, in cirrhotic patients with portal hypertension","volume":"8","author":"Huet","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib162","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/j.1552-4604.1997.tb04299.x","article-title":"Effect of cisapride, a serotonin-4 receptor agonist, on aldosterone secretion: absence of age-related change","volume":"37","author":"Huang","year":"1997","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib163","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1749-6632.1990.tb16912.x","article-title":"Serotonin and migraine","volume":"600","author":"Humphrey","year":"1990","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib164","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1378\/chest.113.1.243","article-title":"5-HT1D\u03b2 receptor mediates the supersensitivity of isolated coronary artery to serotonin in variant angina","volume":"113","author":"Ishida","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib165","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0008-6363(98)00162-X","article-title":"Identification of mRNA for 5-HT1 and 5-HT2 receptor subtypes in human coronary artery","volume":"41","author":"Ishida","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib166","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/hep.1840140645","article-title":"Cardiovascular responses to serotonin in experimental liver disease","volume":"14","author":"Jacob","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib167","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/01.CIR.0000139856.20505.57","article-title":"Involvement of the serotonin 5-HT2B receptor in cardiac hypertrophy linked to sympathetic stimulation","volume":"110","author":"Jaffr\u00e9","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib168","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/BF00169000","article-title":"Positive inotropic responses to 5-HT in human atrial but not in ventricular heart muscle","volume":"346","author":"Jahnel","year":"1992","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib169","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/BF00171339","article-title":"L-type calcium channel activity in human atrial myocytes as influenced by 5-HT","volume":"348","author":"Jahnel","year":"1993","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib170","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/0735-1097(94)90162-7","article-title":"Cell adhesion molecules in coronary heart disease","volume":"24","author":"Jang","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib171","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/sj.bjp.0701336","article-title":"Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7b)","volume":"122","author":"Jasper","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib172","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1748-1716.1987.tb08188.x","article-title":"Mechanical, morphological and pharmacological properties of oesophageal varices and small mesenteric veins in portal hypertensive rabbits","volume":"130","author":"Jensen","year":"1987","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib173","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM199809103391102","article-title":"A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation","volume":"339","author":"Jick","year":"1998","journal-title":"New Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib174","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00008571-200405000-00001","article-title":"Investigation of the association between 5-HT3A receptor gene polymorphisms and efficiency of antiemetic treatment with 5-HT3 receptor antagonists","volume":"14","author":"Kaiser","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib175","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jaut.2005.04.005","article-title":"Autoantibodies against the serotoninergic 5-HT4 receptor and congenital heart block: a reassessment","volume":"25","author":"Kamel","year":"2005","journal-title":"J Autoimmunity"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib176","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/clc.4960200212","article-title":"Disparity between serotonin- and acetylcholine-provoked coronary artery spasm","volume":"20","author":"Kanazawa","year":"1997","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.pharmthera.2005.12.004_bib177","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/humrep\/12.2.361","article-title":"5-Hydroxytryptamine contracts human uterine artery smooth muscle predominantly via 5-HT2 receptors","volume":"12","author":"Karlsson","year":"1997","journal-title":"Human Reproduction"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib178","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/147323000002800602","article-title":"Suppressive effect of sarpogrelate hydrochloride on respiratory failure and right ventricular failure with pulmonary hypertension in patients with systemic sclerosis","volume":"28","author":"Kato","year":"2000","journal-title":"J Inter Med Res"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib179","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/BF00169055","article-title":"Piglet sinoatrial 5-HT receptors resemble human atrial 5-HT4-like receptors","volume":"342","author":"Kaumann","year":"1990","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib180","first-page":"195","article-title":"5-HT4-like receptors in mammalian atria","volume":"34","author":"Kaumann","year":"1991","journal-title":"J Neural Transm [Suppl]"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib181","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0165-6147(94)90058-2","article-title":"Do human atrial 5-HT4 receptors mediate arrhythmias?","volume":"15","author":"Kaumann","year":"1994","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib182","series-title":"The Pharmacology of Functional, Biochemical, and Recombinant Receptor Systems","first-page":"73","article-title":"Gs-protein-coupled receptors in human heart","volume":"vol. 148","author":"Kaumann","year":"2000"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib183","series-title":"Cardiovascular Pharmacology of 5-Hydroxytryptamine","first-page":"127","article-title":"Allosteric modulation of arterial 5-HT2 receptors","author":"Kaumann","year":"1990"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib184","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/sj.bjp.0706501","article-title":"Fading of 5-HT4 receptor-mediated inotropic responses to 5-hydroxytryptamine is caused by phosphodiesterase activity in porcine atrium","volume":"147","author":"Kaumann","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib185","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/BF00173215","article-title":"Both \u03b21- and \u03b22-adrenoceptors mediate catecholamine-evoked arrhythmias in isolated human atrium","volume":"348","author":"Kaumann","year":"1993","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib186","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/BF00170877","article-title":"5-Hydroxytryptamine causes rate-dependent arrhythmias through 5-HT4 receptors in human atrium: facilitation by chronic \u03b2-adrenoceptor blockade","volume":"349","author":"Kaumann","year":"1994","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib187","series-title":"5-HT4 Receptors in the Brain and Periphery","first-page":"127","article-title":"5-Hydroxytryptamine and human heart function: the role of 5-HT4 receptors","author":"Kaumann","year":"1998"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib188","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/S0016-5085(88)80084-2","article-title":"ICI169369 selectively blocks 5-hydroxytryptamine2 receptors and lowers portal pressure in portal hypertension","volume":"95","author":"Kaumann","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib189","first-page":"664","article-title":"A receptor for 5-HT in human atrium","volume":"98","author":"Kaumann","year":"1989","journal-title":"Br J Pharmacol"},{"issue":"Suppl B","key":"10.1016\/j.pharmthera.2005.12.004_bib190","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/eurheartj\/10.suppl_B.29","article-title":"A comparison of the effects of adrenaline and noradrenaline on human heart: the role of adenylate cyclase and contractile force","volume":"10","author":"Kaumann","year":"1989","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib191","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1476-5381.1990.tb14108.x","article-title":"A 5-hydroxytryptamine receptor in human atrium","volume":"100","author":"Kaumann","year":"1990","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib192","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00167212","article-title":"A 5-HT4-like receptor in human right atrium","volume":"344","author":"Kaumann","year":"1991","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib193","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1093\/cvr\/27.12.2094","article-title":"Human arterial constrictor serotonin receptors","volume":"27","author":"Kaumann","year":"1993","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib194","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/01.CIR.90.3.1141","article-title":"Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary artery. 5-HT1-like receptors resemble cloned 5-HT1D\u03b2 receptors","volume":"90","author":"Kaumann","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib195","first-page":"215","article-title":"Contribution of differential efficacy to the pharmacology of human \u03b21- and \u03b22-adrenoceptors","volume":"6","author":"Kaumann","year":"1995","journal-title":"Pharmacol Comm"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib196","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/BF00169181","article-title":"Comparison of the densities of 5-HT4 receptors, \u03b21- and \u03b22-adrenoceptors in human atrium: functional implications","volume":"353","author":"Kaumann","year":"1996","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib197","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1161\/hh2401.100426","article-title":"Contribution of the 5-HT1B receptor to hypoxia-induced pulmonary hypertension. Converging evidence using 5-HT1B-receptor knockout mice and the 5-HT1B\/1D antagonist GR127935","volume":"89","author":"Keegan","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib198","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature01788","article-title":"A cytoplasmic region determines single-channel conductance in 5-HT3 receptors","volume":"424","author":"Kelley","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib199","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/00008571-200010000-00008","article-title":"Pharmacological properties of the naturally occurring Phe-124-Cys variant of the human 5-HT1B receptor: changes in ligand binding, G-protein coupling and second messenger formation","volume":"10","author":"Kiel","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib200","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00008571-200302000-00008","article-title":"Impairment of signal transduction in response to stimulation of the naturally occurring Pro279Leu variant of the h5-HT7(a) receptor","volume":"13","author":"Kiel","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib201","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1161\/01.RES.87.8.705","article-title":"\u03b22-adrenergic and several other G protein-coupled receptors in human atrial membranes activate both Gs and Gi","volume":"87","author":"Kilts","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib202","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/mcpr.1999.0281","article-title":"Mutation screening of human 5-HT2B receptor gene in early-onset obsessive-compulsive disorder","volume":"14","author":"Kim","year":"2000","journal-title":"Mol Cell Probes"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib203","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0016-5085(19)33356-6","article-title":"Circulation times in the splanchnic and hepatic beds in alcoholic liver disease","volume":"63","author":"Kotelanski","year":"1972","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib204","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/sj.bjp.0704588","article-title":"The human 5-HT7 serotonin receptor splice variants: constitutive activity and inverse agonist effects","volume":"135","author":"Krobert","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib205","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s002100000369","article-title":"The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution","volume":"363","author":"Krobert","year":"2001","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib206","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00210-005-1068-0","article-title":"Prucalopride is a partial agonist through human and porcine atrial 5-HT4 receptors. Comparison with recombinant human 5-HT4 splice variants","volume":"371","author":"Krobert","year":"2005","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib207","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1056\/NEJM199903183401107","article-title":"Carcinoid tumours","volume":"340","author":"Kulke","year":"1999","journal-title":"New Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib208","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00008571-200403000-00004","article-title":"Pharmacological and electrophysiological properties of the naturally occurring Pro391Arg variant of the human 5-HT3A receptor","volume":"14","author":"Kurzwelly","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib209","doi-asserted-by":"crossref","first-page":"7821","DOI":"10.1523\/JNEUROSCI.1790-05.2005","article-title":"5-HT7 receptor is coupled to G\u03b1 subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology","volume":"25","author":"Kvachnina","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib210","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/sj.bjp.0701702","article-title":"Receptor mechanisms involved in the 5-HT-induced inotropic action in the rat isolated atrium","volume":"123","author":"L\u00e4er","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib211","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0016-5085(92)90859-W","article-title":"Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation","volume":"103","author":"Laffi","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib212","first-page":"19","article-title":"History of involvement of 5-HT in primary headaches","volume":"vol. 2","author":"Lance","year":"1992"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib213","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1021\/jm020099f","article-title":"5-HT4 receptor ligands: application and new prospects","volume":"46","author":"Langlois","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib214","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/nm764","article-title":"Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension","volume":"8","author":"Launay","year":"2002","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib215","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0306-4522(92)90047-6","article-title":"Serotonin-induced stimulation of cortisol secretion from human adrenoceortical tissue is mediated through activation of a serotonin-4 receptor subtype","volume":"47","author":"Lefebvre","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib217","first-page":"1662","article-title":"Effect of the serotonin-4 receptor agonist zacopride on aldosterone secretion from human adrenal cortex: in vivo and vitro studies","volume":"77","author":"Lefebvre","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib219","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3109\/07435800009048575","article-title":"Effect of serotonin4 (5-HT4) receptor agonists on aldosterone secretion in idiopathic hyperaldosteronism","volume":"26","author":"Lefebvre","year":"2000","journal-title":"Endocr Res"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib220","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1210\/jcem.86.10.7917","article-title":"Production and metabolism of serotonin (5-HT) by the human adrenal cortex: paracrine stimulation of aldosterone secretion by 5-HT","volume":"86","author":"Lefebvre","year":"2001","journal-title":"J Clin Endocr Metab"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib221","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1210\/jcem.87.3.8327","article-title":"Characterization of serotonin4 receptors in adrenocortical aldosterone-producing adenomas: in vivo and in vitro studies","volume":"87","author":"Lefebvre","year":"2002","journal-title":"J Clin Endocr Metab"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib222","first-page":"246","article-title":"Cardiovascular effects of intravenous infusions of 5-hydroxytryptamine in man","volume":"14","author":"Le Mesurier","year":"1959","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib223","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1126\/science.274.5292.1527","article-title":"Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region","volume":"274","author":"Lesch","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib224","first-page":"175","article-title":"Expression of 5-hydroxytryptamine receptors in hepatic stellate cells and action of 5-hydroxytryptamine on biological characteristics of hepatic stellate cells (In Chinese)","volume":"41","author":"Li","year":"2003","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib225","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000139465","article-title":"The hemodynamic effects of AT-112, an analogue of ketanserin in portal hypertensive rats","volume":"54","author":"Lin","year":"1997","journal-title":"Pharmacology"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib226","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/00008571-200412000-00003","article-title":"The human serotonin receptor 2B: coding region polymorphisms and association with vulnerability to illegal drug abuse","volume":"14","author":"Lin","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib227","series-title":"Program No. 841.5. 2005 Abstract Viewer\/Itinerary Planner","article-title":"Is situ oligomerization of G-protein-coupled serotonin and dopamine receptors modulates the regulation of peristaltic reflexes by enteric monoaminergic neurons","author":"Liu","year":"2005"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib228","first-page":"453","article-title":"Pharmacological modulation of the hyperpolarization-activated current (If) in human atrial myocytes: focus on G-protein-coupled receptors","volume":"38","author":"Lonardo","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib229","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0014-2999(92)90293-D","article-title":"5-HT4 receptors, present in piglet atria and sensitive to SDZ 205-557, are absent in papillary muscle","volume":"229","author":"Lorrain","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib230","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/sj.bjp.0702647","article-title":"Functional characterization and m-RNA expression of 5-HT receptors mediating contraction in human umbilical artery","volume":"127","author":"Lovren","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib231","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/01.CIR.77.2.264","article-title":"Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities","volume":"77","author":"Lundin","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib232","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1476-5381.1996.tb15751.x","article-title":"Augmented contraction of human isolated coronary artery by sumatriptan: a possible role for endogenous thromboxane","volume":"119","author":"MaassenVanDenBrink","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib233","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/01.CIR.98.1.25","article-title":"Coronary side-effect potential of current and prospective antimigraine drugs","volume":"98","author":"MaassenVanDenBrink","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib234","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1046\/j.1526-4610.1998.3804288.x","article-title":"5-HT1B receptor polymorphism and clinical response to sumatriptan","volume":"38","author":"MaassenVanDenBrink","year":"1998","journal-title":"Headache"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib235","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.0901-9928.2000.860608.x","article-title":"Human isolated coronary artery contraction to sumatriptan characterised by the selective 5-HT1B\/1D receptor antagonist GR55562","volume":"86","author":"MaassenVanDenBrink","year":"2000","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib236","first-page":"541","article-title":"The effect of i.v. sumatriptan, a selective 5-HT1-receptor agonist on central haemodynamics and the coronary circulation","volume":"34","author":"MacIntyre","year":"1992","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib237","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1476-5381.1996.tb15982.x","article-title":"Evidence for 5-HT1-like receptor-mediated vasoconstriction in human pulmonary artery","volume":"119","author":"MacLean","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib238","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.bjp.0703570","article-title":"5-Hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension","volume":"131","author":"MacLean","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib239","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1476-5381.1989.tb12033.x","article-title":"5-HT1-like receptors requiring functional cyclo-oxygenase and 5-HT2 receptors independent of cyclo-oxygenase mediate contractions of the human umbilical artery","volume":"97","author":"MacLennan","year":"1989","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib241","doi-asserted-by":"crossref","first-page":"9324","DOI":"10.1074\/jbc.275.13.9324","article-title":"PDZ-dependent activation of nitric-oxide synthases by the serotonin 2B receptor","volume":"275","author":"Manivet","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib242","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1164\/rccm.200210-1212OC","article-title":"Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension","volume":"168","author":"Marcos","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib243","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/01.RES.0000126847.27660.69","article-title":"Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension","volume":"94","author":"Marcos","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib244","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/hep.1840090217","article-title":"Serotonin blockade in conscious, unrestrained cirrhotic dogs with portal hypertension","volume":"9","author":"Mastai","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib245","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0016-5085(90)91302-M","article-title":"Ritanserin decreases portal pressure in conscious and unrestrained cirrhotic rats","volume":"98","author":"Mastai","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib246","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0168-8278(90)90117-A","article-title":"The effect of non-protein liquid meals on the hepatic venous pressure gradient in patients with cirrhosis","volume":"11","author":"McCormick","year":"1990","journal-title":"J Hepatol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib247","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1056\/NEJM199103073241002","article-title":"Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina","volume":"324","author":"McFadden","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib248","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/01.CIR.86.1.187","article-title":"Effect of ketanserin on proximal and distal coronary constrictor responses to intracoronary infusion of serotonin in patients with stable angina, patients with variant angina, and control patients","volume":"86","author":"McFadden","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib251","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0169-328X(01)00095-X","article-title":"Quantitative mRNA analysis of five C-terminal splice variants of the human 5-HT4 receptor in the central nervous system by TaqMan real time RT-PCR","volume":"90","author":"Medhurst","year":"2001","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib252","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0306-4522(92)90398-L","article-title":"A critical review of the afferent pathways and the potential chemical mediators involved in cardiac pain","volume":"48","author":"Meller","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib253","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.bjp.0703101","article-title":"Isolation of the serotoninergic 5-HT4(e) receptor from human heart and comparative analysis of its pharmacological profile in C6-glial and CHO cell lines","volume":"129","author":"Mialet","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib254","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/sj.bjp.0703641","article-title":"Pharmacological characterization of the human 5-HT4(d) receptor splice variant stably expressed in Chinese hamster ovary cells","volume":"131","author":"Mialet","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib255","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM198103263041306","article-title":"Is variant angina the coronary manifestation of a generalized vasospastic disorder?","volume":"304","author":"Miller","year":"1981","journal-title":"New Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib256","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0026-895X(25)10488-4","article-title":"Molecular cloning of human 5-hydroxytryptamine3 receptor: heterogeneity in distribution and function among species","volume":"48","author":"Miyake","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib258","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa021451","article-title":"Factors associated with progression of carcinoid heart disease","volume":"348","author":"M\u00f8ller","year":"2003","journal-title":"New Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib259","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF00584763","article-title":"Reflex inhibition of efferent renal sympathetic nerve activity by 5-hydroxytryptamine and nicotine is elicited by different epicardial receptors","volume":"409","author":"Mohr","year":"1987","journal-title":"Pfl\u00fcgers Arch"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib260","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/sj.bjp.0702841","article-title":"5-Hydroxytryptamine receptors mediating contraction in human small muscular pulmonary arteries: importance of the 5-HT1B receptor","volume":"128","author":"Morecroft","year":"1999","journal-title":"Br J Pharmacol"},{"issue":"Gastrointest Liver Physiol 26","key":"10.1016\/j.pharmthera.2005.12.004_bib261","first-page":"G544","article-title":"Pharmacology of portal-systemic collaterals in portal hypertensive rats: role of endothelium","volume":"263","author":"Mosca","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib262","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0248-8663(97)82462-9","article-title":"Physiopathologie du ph\u00e9nom\u00e8ne de Raynaud: donn\u00e9es actuelles","volume":"18","author":"Mourad","year":"1997","journal-title":"Rev M\u00e9d Interne"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib263","first-page":"23","article-title":"Stimulation of aldosterone biosynthesis in vitro by serotonin","volume":"59","author":"M\u00fcller","year":"1968","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib264","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/415219a","article-title":"New ideas about atrial fibrillation 50 years on","volume":"415","author":"Nattel","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib265","doi-asserted-by":"crossref","first-page":"9508","DOI":"10.1073\/pnas.97.17.9508","article-title":"Serotonin 2B receptor is required for heart development","volume":"97","author":"Nebigil","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib266","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1073\/pnas.050282397","article-title":"5-hydroxytryptamine 2B receptor regulates cell-cycle progression: cross-talk with tyrosine kinase pathways","volume":"97","author":"Nebigil","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib267","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1096\/fj.02-1122fje","article-title":"Serotonin is a novel survival factor of cardiomyocytes: mitochondria as a target of 5-HT2B-receptor signaling","volume":"17","author":"Nebigil","year":"2003","journal-title":"FASEB J"},{"issue":"8617","key":"10.1016\/j.pharmthera.2005.12.004_bib268","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(88)92601-3","article-title":"Increase in myocardial Gi-proteins in heart failure","volume":"2","author":"Neumann","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib269","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.1840140636","article-title":"Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in portal hypertensive rats","volume":"14","author":"Nevens","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib270","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1172\/JCI114082","article-title":"The human platelet alloantigens, PIA1 and PIA2, are associated with a leucine33\/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing","volume":"83","author":"Newman","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib271","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0378-1119(03)00503-1","article-title":"Cloning, physical mapping and expression analysis of the human 5-HT3 serotonin receptor-like genes HTR3C, HTR3D and HTR3E","volume":"310","author":"Niesler","year":"2003","journal-title":"Gene"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib272","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0014-2999(99)00114-4","article-title":"Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques","volume":"372","author":"Nilsson","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib273","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/sj.bjp.0702773","article-title":"Contractile 5-HT1B receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry","volume":"128","author":"Nilsson","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib274","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00582206","article-title":"Activation of afferent cardiac sympathetic nerve fibres of the cat by pain producing substances and by noxious heat","volume":"372","author":"Nishi","year":"1977","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib275","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1006\/bbrc.1994.2792","article-title":"Identification of genetic variation in the human serotonin1D\u03b2 receptor gene","volume":"205","author":"N\u00f6then","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib276","doi-asserted-by":"crossref","first-page":"985","DOI":"10.7326\/0003-4819-116-12-985","article-title":"Increased prevalence and chest pain in patients with primary Raynaud disease","volume":"116","author":"O'Keefe","year":"1992","journal-title":"Ann Int Med"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib278","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/sj.mp.4001133","article-title":"Association between serotonin 4 receptor gene polymorphisms and bipolar disorder in Japanese case-control samples and the NIMH Genetics Initiative Bipolar Pedigrees","volume":"7","author":"Ohtsuki","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib279","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/0140-6736(93)93064-8","article-title":"Transmural myocardial infacrtion with sumatriptan","volume":"341","author":"Ottervanger","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib280","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1001\/archneur.1997.00550230054017","article-title":"Characteristics and determinants of sumatriptan-associated chest pain","volume":"54","author":"Ottervanger","year":"1997","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib281","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0026-895X(25)08883-2","article-title":"Serotonin increases calcium current in human atrial myocytes via the newly described 5-hydroxytryptamine4 receptors","volume":"41","author":"Ouadid","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib282","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00005344-199502000-00014","article-title":"Calcium currents in diseased cardiac cells","volume":"25","author":"Ouadid","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib283","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/0006-3223(95)00649-4","article-title":"Two naturally occurring amino acid substitutions of the 5-HT2A receptor: similar prevalence in patients with seasonal affective disorder and controls","volume":"40","author":"Ozaki","year":"1996","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib284","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1046\/j.1471-4159.1997.68052186.x","article-title":"A naturally occurring amino acid substitution of the human serotonin 5-HT2A receptor influences amplitude and timing of intracellular calcium mobilization","volume":"68","author":"Ozaki","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib285","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1358\/mf.2005.27.6.896833","article-title":"5-Hydroxytryptamine-2A receptor gene (HTR2A) candidate polymorphism (T102C): role for human platelet function under pharmacological challenge ex vivo","volume":"27","author":"Ozdener","year":"2005","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib394","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199111213252103","article-title":"Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group","volume":"325","author":"Packer","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib286","first-page":"28","article-title":"Blockade of human and porcine myocardial 5-HT4 receptors by SB203186","volume":"335","author":"Parker","year":"1995","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib287","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1113\/jphysiol.1960.sp006442","article-title":"The stimulation of respiration by 5-hydroxytryptamine in man","volume":"151","author":"Parks","year":"1960","journal-title":"J Physiol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib288","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1476-5381.1989.tb11835.x","article-title":"5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery","volume":"96","author":"Parsons","year":"1989","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib289","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005344-199808000-00008","article-title":"Effects of the novel high-affinity 5-HT1B\/1D-receptor ligand frovatriptan in human isolated basilar and coronary arteries","volume":"32","author":"Parsons","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib290","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.biopsych.2004.06.020","article-title":"The -1438A\/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity","volume":"56","author":"Parsons","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib291","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/sj.bjp.0705553","article-title":"Electrophysiological effects of 5-hydroxytryptamine on isolated human atrial myocytes, and the influence of chronic \u03b2-adrenoceptor blockade","volume":"140","author":"Pau","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib292","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1124\/jpet.104.076869","article-title":"Electrophysiological effects of prucalopride, a novel enterokinetic agent, on isolated atrial myocytes from patients treated with \u03b2-adrenoceptor antagonists","volume":"313","author":"Pau","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib293","first-page":"453","article-title":"Reduced effects of 5-hydroxytryptamine on L-type calcium current in atrial cells from patients with atrial fibrillation","volume":"26","author":"Pau","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib294","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/hrt.39.9.967","article-title":"Origin of ventricular reflexes caused by coronary arteriography","volume":"39","author":"Perez-Gomez","year":"1977","journal-title":"Br Heart J"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib295","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/hrt.42.1.81","article-title":"Prinzmetal's angina: reflex cardiovascular responses during episodes of pain","volume":"42","author":"Perez-Gomez","year":"1979","journal-title":"Br Heart J"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib296","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1124\/mol.61.1.85","article-title":"Differences in signal transduction of two 5-HT4 receptor splice variants: compound specificity and dual coupling with G\u03b1s- and G\u03b1i\/o proteins","volume":"61","author":"Pindon","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib297","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0008-6363(98)00198-9","article-title":"Effect of 5-hydroxytryptamine (5-HT) on the pacemaker current, If, in human atrial myocytes","volume":"40","author":"Pino","year":"1998","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib298","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitts","year":"1999","journal-title":"New Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib299","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitts","year":"2003","journal-title":"New Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib300","doi-asserted-by":"crossref","first-page":"20812","DOI":"10.1074\/jbc.M112216200","article-title":"5-Hydroxytryptamine 4(a) receptor is coupled to the G\u03b1 subunit of heterotrimeric G13 protein","volume":"277","author":"Ponimaskin","year":"2002","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.pharmthera.2005.12.004_bib301","article-title":"Ketanserin for Raynaud's phenomenon in progressive systemic sclerosis","author":"Pope","year":"2000","journal-title":"Cochrane Database Syt Rev"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib302","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/PL00005056","article-title":"SB216641 and BRL-15572\u2013compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors","volume":"356","author":"Price","year":"1997","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib303","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/sj.bjp.0703254","article-title":"An improved in vivo bioassay for the study of 5-HT4 receptors in the human isolated large intestinal circular muscle","volume":"129","author":"Prins","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib304","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.cardiores.2004.11.017","article-title":"Appearance of a ventricular 5-HT4 receptor-mediated inotropic response to serotonin in heart failure","volume":"65","author":"Qvigstad","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib305","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1161\/01.RES.0000176970.22603.8d","article-title":"Dual serotonergic regulation of ventricular contractile force through 5-HT2A and 5-HT4 receptors induced in the acute failing heart","volume":"97","author":"Qvigstad","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib395","series-title":"Proceedings of the 25th European Section Meeting, International Society for Heart Research, Troms\u00f8, Norway, June 21-25, 2005","first-page":"7","article-title":"Rationale for treatment of heart failure by blockade of ventricular serotonin receptors appearing in heart failure","author":"Qvigstad","year":"2005"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib307","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1161\/01.CIR.100.19.2010","article-title":"Electrophysiological and antiarrhythmic effects of the atrial selective 5-HT4 receptor antagonist RS-100302 in experimental atrial flutter and fibrillation","volume":"100","author":"Rahme","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib308","first-page":"F3","article-title":"Immunohistochemical mapping of cellular and subcellular distribution of 5-HT1A receptors in rat and human kidneys","volume":"264","author":"Raymond","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib309","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0163-7258(01)00169-3","article-title":"Multiplicity of mechanisms of serotonin receptor signal transduction","volume":"92","author":"Raymond","year":"2001","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib310","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2125.1999.00851.x","article-title":"Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation","volume":"47","author":"Razzaque","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib311","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1046\/j.0306-5251.2001.01536.x","article-title":"5-HT1B-receptors and vascular reactivity in human isolated blood vessels: assessment of the potential craniovascular selectivity of sumatriptan","volume":"53","author":"Razzaque","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib312","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/bmj.287.6389.381-a","article-title":"Mechanism of the antihypertensive action of ketanserin in man","volume":"287","author":"Reimann","year":"1983","journal-title":"Br Med J"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib313","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0306-4522(98)00196-1","article-title":"Endothelial expression of the 5-HT1B antimigraine drug receptor in rat and human brain microvessels","volume":"86","author":"Riad","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib314","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(97)80010-4","article-title":"PIA1\/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis","volume":"349","author":"Ridker","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib315","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0028-3908(97)00026-9","article-title":"Importance of h5-HT1B receptor selectivity for 5-HT terminal autoreceptor activity: an in vivo microdialysis study in freely-moving guinea pig","volume":"35","author":"Roberts","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib316","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/sj.bjp.0703537","article-title":"Inhibition of sustained hypoxic vasoconstriction by Y-27632 in isolated intrapulmonary arteries and perfused lung of the rat","volume":"131","author":"Robertson","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib317","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/01.CIR.92.4.790","article-title":"Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography","volume":"92","author":"Robiolio","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib318","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00210-002-0636-9","article-title":"Characterization of 5-HT receptor subtypes mediating contraction in human umbilical vein: 1. Evidence of involvement of 5-HT2A receptors using functional and radioligand binding assays","volume":"366","author":"Rogines-Velo","year":"2002","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib319","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s00210-002-0637-8","article-title":"Characterization of 5-HT receptor subtypes mediating contraction in human umbilical vein. 1. Evidence of involvement of 5-HT1B receptors using functional studies","volume":"366","author":"Rogines-Velo","year":"2002","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib320","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0002-9149(99)00896-6","article-title":"Chronic treatment with phentermine combined with fenfluramine lowers plasma serotonin","volume":"85","author":"Rothman","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib321","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1161\/01.CIR.102.23.2836","article-title":"Evidence for possible involvement of 5-HT2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic mechanisms","volume":"102","author":"Rothman","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib323","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0735-1097(87)80462-X","article-title":"Vasoconstrictor activity of coronary sinus plasma from patients with coronary artery disease","volume":"9","author":"Rubanyi","year":"1987","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib324","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1540-8167.2000.tb00068.x","article-title":"Left atrial myocardial extension onto pulmonary veins in humans: anatomic observations relevant for atrial arrhythmias","volume":"11","author":"Saito","year":"2001","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib325","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1046\/j.1440-1827.2000.01053.x","article-title":"Ileal carcinoid tumor complicating carcinoid heart disease and secondary retroperitoneal fibrosis","volume":"50","author":"Sakai","year":"2000","journal-title":"Pathol Int"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib326","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/BF00176614","article-title":"A 5-HT4-like receptor in human left atrium","volume":"345","author":"Sanders","year":"1992","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib327","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1161\/01.CIR.92.9.2526","article-title":"Sensitization of human atrial 5-HT4 receptors by chronic \u03b2 blocker treatment","volume":"92","author":"Sanders","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib328","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/BF00167185","article-title":"Chronic \u03b21-adrenoceptor blockade sensitises the H1- and H2-receptor systems in human atrium: role of cyclic nucleotides","volume":"353","author":"Sanders","year":"1996","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib329","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/geno.2000.6411","article-title":"Genetic diversity of the human serotonin receptor 1B (HTR1B) gene","volume":"72","author":"Sanders","year":"2001","journal-title":"Genomics"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib330","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1517\/14622416.3.6.745","article-title":"DNA variation and psychopharmacology of the human serotonin receptor 1B (HTR1B) gene","volume":"3","author":"Sanders","year":"2002","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib331","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1124\/mi.3.6.319","article-title":"Serotonin 5-HT2 receptors: molecular and genomic diversity","volume":"3","author":"Sanders-Bush","year":"2003","journal-title":"Mol Interv"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib332","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.CIR.0000079172.43229.CD","article-title":"Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction","volume":"108","author":"Sauer","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib333","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/BF00168735","article-title":"5-Hydroxytryptamine-induced increase in left ventricular dP\/dtmax does not suggest the presence of ventricular 5-HT4 receptors in the pig","volume":"346","author":"Saxena","year":"1992","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib334","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1476-5381.1996.tb16687.x","article-title":"Functional, endogenously expressed 5-hydroxytryptamine 5-HT7 receptors in human vascular smooth muscle cells","volume":"117","author":"Schoeffter","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib335","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/BF00169001","article-title":"5-Hydroxytryptamine increases contractile force in porcine right atrium but not in left ventricle","volume":"346","author":"Schoemaker","year":"1992","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib336","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0014-2999(93)90417-G","article-title":"5-Hydroxytryptamine stimulates human isolated atrium but not ventricle","volume":"230","author":"Schoemaker","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib337","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1096-7192(03)00090-8","article-title":"The combination of glycoprotein IIIa PIA polymorphism with polymorphism of serotonin transporter as an independent strong risk factor for the occurrence of coronary thrombosis","volume":"79","author":"Schwartz","year":"2003","journal-title":"Mol Genetics Metab"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib338","first-page":"337","article-title":"Selective antagonism of S2-serotonergic receptors relieves but does not prevent cold induced vasoconstriction in primary Raynaud's phenomenon","volume":"13","author":"Seibold","year":"1986","journal-title":"J Rheumatol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib339","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1388-9842(03)00005-9","article-title":"Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin","volume":"5","author":"Serebruany","year":"2003","journal-title":"Eur J Heart Failure"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib340","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1124\/mol.63.6.1223","article-title":"3,4-Methylenedioxymethamphetamine (MDMA, \u2018Ecstacy\u2019) induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro","volume":"63","author":"Setola","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib341","first-page":"H1790","article-title":"Endocardium modulates myocardial inotropic responses to 5-hydroxytryptamine","volume":"257","author":"Shah","year":"1989","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib342","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0014-2999(90)90027-4","article-title":"Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378","volume":"176","author":"Sharp","year":"1990","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib343","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1172\/JCI112128","article-title":"Central serotonergic stimulation of aldosterone secretion","volume":"76","author":"Shenker","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib344","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1046\/j.1468-2982.1999.1910851.x","article-title":"Possible antimigraine mechanisms of action of the 5-HT1F receptor agonist LY334370","volume":"19","author":"Shepheard","year":"1999","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib345","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.thromres.2003.12.002","article-title":"Serotonin-2A receptor gene polymorphisms are associated with serotonin-induced platelet aggregation","volume":"112","author":"Shimizu","year":"2003","journal-title":"Thromb Res"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib346","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s002280050172","article-title":"Effects of metoprolol on myocardial \u03b2-adrenoceptors and Gi\u03b1 proteins in patients with congestive heart failure","volume":"51","author":"Sigmund","year":"1996","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib347","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1095-6433(98)10041-7","article-title":"Increased reactivity to 5-hydroxytryptamine of portal veins from mice infected with Schistosoma mansoni","volume":"120","author":"Silva","year":"1998","journal-title":"Comp Biochem Physiol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib348","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/01.CIR.99.3.411","article-title":"Monoamine- and histamine-synthesizing enzymes and neurotransmitters within neurons of adult human cardiac ganglia","volume":"99","author":"Singh","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib349","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/01.RES.45.5.629","article-title":"Serotonin: metabolism in the normal and failing heart","volume":"45","author":"Sole","year":"1979","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib350","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s002280050125","article-title":"Effects of metoclopramide and tropisetron on aldosterone secretion possibly due to agonism and antagonism at the 5-HT4 receptor","volume":"50","author":"Sommers","year":"1996","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib351","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1152\/physrev.00030.2003","article-title":"Control of aldosterone secretion: a model for convergence in cellular signaling pathways","volume":"84","author":"Sp\u00e4t","year":"2004","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib352","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.mp.4000342","article-title":"A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter","volume":"3","author":"Spurlock","year":"1998","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib353","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/00006254-200009000-00024","article-title":"Serotonin antagonism and serotonin antagonists in pregnancy: role of ketanserin","volume":"55","author":"Steyn","year":"2000","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib354","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0006-3223(01)01366-X","article-title":"Association study of novel human serotonin 5-HT1B polymorphisms with alcohol dependence in Taiwanese Han","volume":"51","author":"Sun","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib355","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ajmg.b.20060","article-title":"Association of a haplotype in the serotonin 5-HT4 receptor gene (HTR4) with Japanese schizophrenia","volume":"121","author":"Suzuki","year":"2003","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib356","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1161\/01.CIR.82.5.1730","article-title":"Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS trial study group","volume":"82","author":"Swedberg","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib357","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0022-510X(93)90057-6","article-title":"Sumatriptan in the acute treatment of migraine","volume":"114","author":"Tansey","year":"1993","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib358","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1200\/JCO.2003.05.164","article-title":"Variations in the 5-hydroxytryptamine type 3B receptor gene as predictors of the efficacy of antiemetic treatment in cancer patients","volume":"21","author":"Tremblay","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib359","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1152\/ajplegacy.1974.226.5.1094","article-title":"Excitation of afferent cardiac sympathetic nerve fibers during coronary occlusion","volume":"226","author":"Uchida","year":"1974","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib360","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0014-5793(95)00828-W","article-title":"Expression of serotonin receptor mRNAs in blood vessels","volume":"370","author":"Ullmer","year":"1995","journal-title":"FEBS Letters"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib361","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1476-5381.1996.tb16700.x","article-title":"5-HT2B receptor-mediated calcium release from ryanodine-sensitive intracellular stores in human pulmonary artery endothelial cells","volume":"117","author":"Ullmer","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib362","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1161\/01.CIR.79.1.116","article-title":"Transcardiac serotonin concentrations is increased in selected patients with limiting angina and complex coronary lesion morphology","volume":"79","author":"Van den Berg","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib363","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0014-2999(00)00712-3","article-title":"Pharmacological analysis of contractile effects of eletriptan and sumatriptan on human isolated blood vessels","volume":"407","author":"Van den Broek","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib364","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.1468-2982.2002.00295.x","article-title":"Characterization of sumatriptan-induced contractions in human isolated blood vessels using selective 5-HT1B and 5-HT1D receptor antagonists and in situ hybridisation","volume":"22","author":"Van den Broek","year":"2002","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib365","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1046\/j.1471-4159.1997.69051810.x","article-title":"Cloning and expression of a human serotonin 5-HT4 receptor cDNA","volume":"69","author":"Van den Wyngaert","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib366","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1161\/01.HYP.11.2.111","article-title":"Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin","volume":"11","author":"Vanhoutte","year":"1988","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib367","first-page":"S55","article-title":"Augmentation of vasoconstrictor responses to serotonin by acute and chronic factors: inhibition by ketanserin","volume":"4","author":"Van Nueten","year":"1986","journal-title":"J Hypertens Suppl"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib368","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0022-3565(25)32655-8","article-title":"Vascular effects of ketanserin (R41468), a novel antagonist of 5-HT2 serotonergic receptors","volume":"218","author":"Van Nueten","year":"1981","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 1","key":"10.1016\/j.pharmthera.2005.12.004_bib369","first-page":"S10","article-title":"Interaction between S2-serotonergic and alpha 1-adrenergic receptor activities at vascular sites","volume":"11","author":"Van Nueten","year":"1988","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib370","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0014-2999(91)90317-J","article-title":"5-Hydroxytryptamine-induced vasodilatation in the isolated perfused rat kidney: are endothelial 5-HT1A receptors involved?","volume":"201","author":"Verbeuren","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib371","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1476-5381.1996.tb15188.x","article-title":"Participation of 5-HT1-like and 5-HT2A receptors in the contraction of human temporal artery by 5-hydroxytryptamine and related drugs","volume":"117","author":"Verheggen","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib372","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/sj.bjp.0701929","article-title":"5-HT1B receptor-mediated contractions in human temporal artery: evidence from selective antagonists and 5-HT receptor mRNA expression","volume":"124","author":"Verheggen","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib373","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00210-004-0878-9","article-title":"Functional 5-HT receptors in human occipital artery","volume":"369","author":"Verheggen","year":"2004","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib374","unstructured":"Verheggen, R., Werner, I., Br\u00fcss, M., G\u00f6thert, M., & Kaumann, A. J. (submitted for publication). 5-Hydroxytryptamine-induced contraction of human temporal arteries coexpressing 5-HT2A receptors and wild-type or variant (Phe124Cys) 5-HT1B receptors: increased contribution of 5-HT1B receptors to the total contractile amplitude in arteries from Phe124Cys heterozygous individuals. Pharmacogen Genom."},{"key":"10.1016\/j.pharmthera.2005.12.004_bib375","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.CIR.100.5.483","article-title":"Serotonin is associated with coronary artery disease and cardiac events","volume":"100","author":"Vikenes","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib376","first-page":"21","article-title":"Relationship between myocardial remodelling and neurohumoral activation in patients with cardiac failure","volume":"79","author":"Vizir","year":"2001","journal-title":"Klin Med (Mosk)"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib377","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/hep.1840090114","article-title":"Long-term hemodynamic effects of ketanserin, a 5-hydroxytryptamine blocker, in portal hypertensive patients","volume":"9","author":"Vorobioff","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib378","doi-asserted-by":"crossref","first-page":"H867","DOI":"10.1152\/ajpheart.00617.2002","article-title":"Role of serotonin in thromboxane A2-induced coronary chemoreflex","volume":"284","author":"Wacker","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib379","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00210-005-1035-9","article-title":"[3H]LY334370, a novel radioligand for the 5-HT1F receptor: I. In vitro characterization and binding properties","volume":"371","author":"Wainscott","year":"2005","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib380","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1600-0773.1996.tb00179.x","article-title":"Characteristics of contractile 5-HT receptors in isolated human omental arteries: presence of 5-HT1 and 5-HT2 receptors","volume":"78","author":"Wallerstedt","year":"1996","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib381","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0092-8674(03)01014-6","article-title":"Serotonylation of small GTPases is a signal transduction pathway that triggers platelet \u03b1-granule release","volume":"115","author":"Walther","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib382","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJM199604253341703","article-title":"A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis","volume":"334","author":"Weiss","year":"1996","journal-title":"New Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib383","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1176\/appi.ajp.158.12.2074","article-title":"Influence of serotonin-transporter-linked promoter region polymorphism on platelet activation in geriatric depression","volume":"158","author":"Whyte","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib384","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMcp013013","article-title":"Raynaud's phenomenon","volume":"347","author":"Wigley","year":"2002","journal-title":"New Engl J Med"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib385","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1161\/01.CIR.92.7.1954","article-title":"Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats","volume":"92","author":"Wijffels","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib386","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1136\/bmj.304.6839.1415","article-title":"Coronary vasospasm induced by subcutaneous sumatriptan","volume":"304","author":"Willett","year":"1992","journal-title":"Br Med J"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib387","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(05)62413-0","article-title":"Meta-analysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia. EMASS Collaborative Group, European Multicentre Association Study of Schizophrenia","volume":"349","author":"Williams","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib388","first-page":"436","article-title":"Serotonin, If and human atrial arrhythmia","volume":"40","author":"Workman","year":"1998","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib389","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0021-9150(99)00356-1","article-title":"T102C polymorphism of the serotonin (5-HT) 2A receptor gene in patients with non-fatal acute myocardial infarction","volume":"150","author":"Yamada","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib390","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00005344-199607000-00002","article-title":"5-HT1-like receptor-mediated contraction in the human internal mammary artery","volume":"28","author":"Yildiz","year":"1996","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib391","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/0003-4975(96)00674-1","article-title":"Hypertension increases the contractions to sumatriptan in the human internal mammary artery","volume":"62","author":"Yildiz","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib392","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00003081-199235020-00014","article-title":"Pathogenesis of preemplampsia: a hypothesis","volume":"35","author":"Zeeman","year":"1992","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2005.12.004_bib393","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/01.ATV.5.1.2","article-title":"Platelet activation","volume":"5","author":"Zucker","year":"1985","journal-title":"Arteriosclerosis"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372580500286X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372580500286X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:49:05Z","timestamp":1759009745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016372580500286X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":384,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S016372580500286X"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2005.12.004","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-Hydroxytryptamine receptors in the human cardiovascular system","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2005.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}